Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Beijing Biostar Pharmaceuticals Co., Ltd. Class H ( (HK:2563) ) has issued an announcement.
Beijing Biostar Pharmaceuticals Co., Ltd. announced the successful passing of all resolutions at its Annual General Meeting held on August 25, 2025. The resolutions included approvals of the company’s financial reports, remuneration packages, and a change in auditors, as well as a mandate for the board to repurchase H shares. This outcome reflects strong shareholder support and positions the company for continued strategic growth.
More about Beijing Biostar Pharmaceuticals Co., Ltd. Class H
Beijing Biostar Pharmaceuticals Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating in the pharmaceutical industry. The company is involved in the development and production of pharmaceutical products, focusing on the Chinese market.
Average Trading Volume: 631,110
Technical Sentiment Signal: Hold
See more insights into 2563 stock on TipRanks’ Stock Analysis page.